Wed, October 3, 2018
Tue, October 2, 2018
Mon, October 1, 2018
Fri, September 28, 2018
Thu, September 27, 2018
Wed, September 26, 2018
Tue, September 25, 2018
Mon, September 24, 2018
Fri, September 21, 2018
Thu, September 20, 2018
Wed, September 19, 2018
Tue, September 18, 2018
Mon, September 17, 2018
Fri, September 14, 2018
Thu, September 13, 2018
Wed, September 12, 2018
Tue, September 11, 2018

Charles Duncan Initiated (CARA) at Buy and Held Target at $27 on, Sep 21st, 2018


//stocks-investing.news-articles.net/content/201 .. -buy-and-held-target-at-27-on-sep-21st-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation



Charles Duncan of Cantor Fitzgerald, Initiated "Cara Therapeutics, Inc." (CARA) at Buy and Held Target at $27 on, Sep 21st, 2018.

Charles has made no other calls on CARA in the last 4 months.



There are 4 other peers that have a rating on CARA. Out of the 4 peers that are also analyzing CARA, 0 agree with Charles's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Charles


  • Matthew Andrews of "Jefferies" Initiated at Strong Buy and Held Target at $30 on, Thursday, September 13th, 2018
  • Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $24 on, Wednesday, August 15th, 2018
  • Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $26 on, Wednesday, August 8th, 2018
  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $24 on, Wednesday, May 23rd, 2018

Publication Contributing Sources